Stefan Gazdoiu

Stefan Gazdoiu is a seasoned medical science liaison with extensive experience in oncology and rare diseases. Currently serving as a Senior Medical Science Liaison at UroGen Pharma, Stefan supports the treatment of low-grade upper tract urothelial cancer. Prior roles include Senior Medical Science Liaison positions at Recordati Rare Diseases and MacroGenics, where responsibilities involved overseeing research studies, leading educational initiatives, and providing expert medical support for oncology treatments. Stefan's career encompasses significant contributions at Novartis Oncology, managing multiple product launches and engaging with healthcare professionals to drive scientific discussions and educational strategies. Stefan holds a PhD in Biomedical Sciences from the Icahn School of Medicine at Mount Sinai, an MBA from Vlerick Business School, and an online certificate in Immuno-oncology from Harvard Medical School.